Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve PFA the notice of Board Meeting
Awaiting price reaction for this filing.
Advik Laboratories Ltd (now renamed MPS Pharmaa Limited) has informed BSE that its Board of Directors will meet on Friday, 14 November 2025 at 12:00 PM at its corporate office in New Delhi. The main agenda is to consider and approve the Un-Audited Financial Results along with the Limited Review Report for the quarter and half year ended 30 September 2025. The company has also noted that the trading window for insiders is already closed and will remain shut until 16 November 2025, as per SEBI insider trading norms. No financial numbers have been disclosed yet — they will be released after the board meeting.
This is a routine compliance announcement ahead of the Q2 FY26 earnings release and does not by itself impact the stock price. Investors should watch for the actual results on/after 14 November 2025 to gauge the company's quarterly performance and any business updates.